132 related articles for article (PubMed ID: 26119998)
21. Pyrrole-imidazole polyamide-mediated silencing of KCNQ1OT1 expression induces cell death in Wilms' tumor cells.
Yoshizawa S; Fujiwara K; Sugito K; Uekusa S; Kawashima H; Hoshi R; Watanabe Y; Hirano T; Furuya T; Masuko T; Ueno T; Fukuda N; Soma M; Ozaki T; Koshinaga T; Nagase H
Int J Oncol; 2015 Jul; 47(1):115-21. PubMed ID: 25998555
[TBL] [Abstract][Full Text] [Related]
22. A novel gene regulator, pyrrole-imidazole polyamide targeting ABCA1 gene increases cholesterol efflux from macrophages and plasma HDL concentration.
Tsunemi A; Ueno T; Fukuda N; Watanabe T; Tahira K; Haketa A; Hatanaka Y; Tanaka S; Matsumoto T; Matsumoto Y; Nagase H; Soma M
J Mol Med (Berl); 2014 May; 92(5):509-21. PubMed ID: 24463557
[TBL] [Abstract][Full Text] [Related]
23. Development of a novel gene silencer pyrrole-imidazole polyamide targeting human connective tissue growth factor.
Wan JX; Fukuda N; Ueno T; Watanabe T; Matsuda H; Saito K; Nagase H; Matsumoto Y; Matsumoto K
Biol Pharm Bull; 2011; 34(10):1572-7. PubMed ID: 21963497
[TBL] [Abstract][Full Text] [Related]
24. Cell-cycle regulation of the DNA topoisomerase IIalpha promoter is mediated by proximal CCAAT boxes: possible involvement of acetylation.
Adachi N; Nomoto M; Kohno K; Koyama H
Gene; 2000 Mar; 245(1):49-57. PubMed ID: 10713444
[TBL] [Abstract][Full Text] [Related]
25. The effects of 1,4-benzoquinone on c-Myb and topoisomerase II in K-562 cells.
Singh R; Winn LM
Mutat Res; 2008 Oct; 645(1-2):33-8. PubMed ID: 18778717
[TBL] [Abstract][Full Text] [Related]
26. Regulation of the human topoisomerase IIalpha gene promoter in confluence-arrested cells.
Isaacs RJ; Harris AL; Hickson ID
J Biol Chem; 1996 Jul; 271(28):16741-7. PubMed ID: 8663303
[TBL] [Abstract][Full Text] [Related]
27. HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIalpha.
Stros M; Polanská E; Struncová S; Pospísilová S
Nucleic Acids Res; 2009 Apr; 37(7):2070-86. PubMed ID: 19223331
[TBL] [Abstract][Full Text] [Related]
28. Synthetic pyrrole-imidazole polyamide inhibits expression of the human transforming growth factor-beta1 gene.
Lai YM; Fukuda N; Ueno T; Matsuda H; Saito S; Matsumoto K; Ayame H; Bando T; Sugiyama H; Mugishima H; Serie K
J Pharmacol Exp Ther; 2005 Nov; 315(2):571-5. PubMed ID: 16120815
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic gene regulation using pyrrole-imidazole polyamides.
Yu Z; Pandian GN; Hidaka T; Sugiyama H
Adv Drug Deliv Rev; 2019 Jul; 147():66-85. PubMed ID: 30742856
[TBL] [Abstract][Full Text] [Related]
30. Preclinical Study of DNA-Recognized Peptide Compound Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Progressive Renal Diseases in the Common Marmoset.
Otsuki M; Fukuda N; Inoue T; Mineshige T; Otsuki T; Horikoshi S; Endo M; Abe M
Molecules; 2019 Sep; 24(17):. PubMed ID: 31480595
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of major-groove-binding proteins by pyrrole-imidazole polyamides with an Arg-Pro-Arg positive patch.
Bremer RE; Baird EE; Dervan PB
Chem Biol; 1998 Mar; 5(3):119-33. PubMed ID: 9545429
[TBL] [Abstract][Full Text] [Related]
32. RNA binding properties of novel gene silencing pyrrole-imidazole polyamides.
Iguchi A; Fukuda N; Takahashi T; Watanabe T; Matsuda H; Nagase H; Bando T; Sugiyama H; Shimizu K
Biol Pharm Bull; 2013; 36(7):1152-8. PubMed ID: 23628892
[TBL] [Abstract][Full Text] [Related]
33. Novel C8-linked pyrrolobenzodiazepine (PBD)-heterocycle conjugates that recognize DNA sequences containing an inverted CCAAT box.
Brucoli F; Hawkins RM; James CH; Wells G; Jenkins TC; Ellis T; Hartley JA; Howard PW; Thurston DE
Bioorg Med Chem Lett; 2011 Jun; 21(12):3780-3. PubMed ID: 21570842
[TBL] [Abstract][Full Text] [Related]
34. Development of gene silencing pyrrole-imidazole polyamide targeting the TGF-beta1 promoter for treatment of progressive renal diseases.
Matsuda H; Fukuda N; Ueno T; Tahira Y; Ayame H; Zhang W; Bando T; Sugiyama H; Saito S; Matsumoto K; Mugishima H; Serie K
J Am Soc Nephrol; 2006 Feb; 17(2):422-32. PubMed ID: 16371433
[TBL] [Abstract][Full Text] [Related]
35. An extended pyrrolobenzodiazepine-polyamide conjugate with selectivity for a DNA sequence containing the ICB2 transcription factor binding site.
Brucoli F; Hawkins RM; James CH; Jackson PJ; Wells G; Jenkins TC; Ellis T; Kotecha M; Hochhauser D; Hartley JA; Howard PW; Thurston DE
J Med Chem; 2013 Aug; 56(16):6339-51. PubMed ID: 23889553
[TBL] [Abstract][Full Text] [Related]
36. CBF/NF-Y functions both in nucleosomal disruption and transcription activation of the chromatin-assembled topoisomerase IIalpha promoter. Transcription activation by CBF/NF-Y in chromatin is dependent on the promoter structure.
Coustry F; Hu Q; de Crombrugghe B; Maity SN
J Biol Chem; 2001 Nov; 276(44):40621-30. PubMed ID: 11514576
[TBL] [Abstract][Full Text] [Related]
37. Smurf2-Mediated Stabilization of DNA Topoisomerase IIα Controls Genomic Integrity.
Emanuelli A; Borroni AP; Apel-Sarid L; Shah PA; Ayyathan DM; Koganti P; Levy-Cohen G; Blank M
Cancer Res; 2017 Aug; 77(16):4217-4227. PubMed ID: 28611047
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of DNA binding by NF-kappa B with pyrrole-imidazole polyamides.
Wurtz NR; Pomerantz JL; Baltimore D; Dervan PB
Biochemistry; 2002 Jun; 41(24):7604-9. PubMed ID: 12056891
[TBL] [Abstract][Full Text] [Related]
39. E1A specifically enhances sensitivity to topoisomerase IIalpha targeting anticancer drug by up-regulating the promoter activity.
Zhou Z; Guan H; Kleinerman ES
Mol Cancer Res; 2005 May; 3(5):271-5. PubMed ID: 15886298
[TBL] [Abstract][Full Text] [Related]
40. Modulation of DNA topoisomerase II alpha promoter activity by members of the Sp (specificity protein) and NF-Y (nuclear factor Y) families of transcription factors.
Magan N; Szremska AP; Isaacs RJ; Stowell KM
Biochem J; 2003 Sep; 374(Pt 3):723-9. PubMed ID: 12769819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
